Form 4: Cytokinetics Director Robert E. Landry Reports Stock and Option Awards

Director Robert E. Landry reports the acquisition of restricted stock units and stock options in Cytokinetics Inc.

Summary

• Robert E. Landry, a director of Cytokinetics Inc., filed a Form 4 detailing changes in beneficial ownership.
• On May 14, 2025, Landry acquired 7,333 restricted stock units (RSUs) and 10,880 non-qualified stock options.
• The RSUs will vest in one installment on the earlier of the one-year anniversary of the grant date or the date of the issuer's annual meeting of stockholders for the subsequent calendar year, contingent upon continuous service as a director.
• The stock options vest monthly in equal installments over a year, also contingent on continuous service as a director.
• The exercise price for the stock options is $30.
• Following the reported transactions, Landry beneficially owns 7,333 shares of common stock and 10,880 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock and option awards, which doesn't inherently indicate positive or negative sentiment but reflects standard compensation practices.

Positives

• The acquisition of stock and options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting schedules for the RSUs and stock options are contingent upon the director's continuous service, aligning their interests with the company's long-term performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for insights into management's sentiment and expectations for the company's future.

Stakeholder Impact

• The transactions may have a minor positive impact on shareholder sentiment, as they indicate the director's continued commitment to the company.

Key Dates

Keywords

Form 4, Cytokinetics, Director, Stock Options, Restricted Stock Units, Beneficial Ownership, Landry